Treatment of Recurrent Pregnancy Loss Using Mesenchymal Stem Cells
Condition(s):Recurrent Pregnancy LossLast Updated:August 29, 2022Not yet recruiting
Include Studies Not Open or Pending
Condition(s):Recurrent Pregnancy LossLast Updated:August 29, 2022Not yet recruiting
Condition(s):Mesenchymal Stem Cell; COVID-19 PneumoniaLast Updated:January 18, 2023Recruiting
Condition(s):Primary Central Nervous System LymphomaLast Updated:May 1, 2023Recruiting
Condition(s):Vaginal Discharge; Sexually Transmitted DiseasesLast Updated:August 4, 2023Not yet recruiting
Condition(s):Hand-Foot Syndrome; Breast CancerLast Updated:May 10, 2023Recruiting
Condition(s):Multiple MyelomaLast Updated:June 29, 2023Recruiting
Condition(s):Sepsis; Septic ShockLast Updated:March 12, 2024Not yet recruiting
Condition(s):Multiple Myeloma; Fatigue; Pain; DepressionLast Updated:October 10, 2023Not yet recruiting
Condition(s):Magnetic Resonance Imaging; Pediatric; Virtual Reality; AnxietyLast Updated:December 11, 2023Recruiting
Condition(s):Magnetic Resonance Imaging; Pediatric; Virtual Reality; AnxietyLast Updated:November 18, 2023Recruiting
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.